https://www.indianpharmapost.com/modernas-covid-19-vaccine-approved-in-australia-for-children-6-11-years-112852022-02-17T00:00:00+05:30always0.9https://www.indianpharmapost.com/usfda-accepts-for-priority-review-bristol-myers-squibbs-supplemental-bla-for-breyanzi-112952022-02-17T00:00:00+05:30always0.9https://www.indianpharmapost.com/centauri-therapeutics-closes-24-million-series-a-investment-round-112942022-02-17T00:00:00+05:30always0.9https://www.indianpharmapost.com/usfda-approves-lupins-supplemental-new-drug-application-for-solosec-112972022-02-17T00:00:00+05:30always0.9https://www.indianpharmapost.com/perkinelmers-sirion-biotech-and-crg-to-develop-diabetes-gene-therapy-112932022-02-17T00:00:00+05:30always0.9https://www.indianpharmapost.com/asahi-kasei-to-build-new-filter-assembly-plant-in-japan-112922022-02-17T00:00:00+05:30always0.9https://www.indianpharmapost.com/pebble-engages-md-anderson-to-evaluate-multi-cannabinoid-formulations-in-ovarian-cancer-112912022-02-17T00:00:00+05:30always0.9https://www.indianpharmapost.com/swissmedic-approves-beigenes-brukinsa-112902022-02-17T00:00:00+05:30always0.9https://www.indianpharmapost.com/rajiv-gupta-to-retire-as-chairman-of-avantor-112892022-02-17T00:00:00+05:30always0.9https://www.indianpharmapost.com/jubilant-ingrevia-commissions-diketene-derivatives-facility-112882022-02-17T00:00:00+05:30always0.9https://www.indianpharmapost.com/kato-wins-usfda-approval-for-studies-in-retinal-disorder-112872022-02-17T00:00:00+05:30always0.9https://www.indianpharmapost.com/center-for-breakthrough-medicines-launches-analytical-testing-112862022-02-17T00:00:00+05:30always0.9https://www.indianpharmapost.com/ipp-to-organize-e-conference-on-indian-pharma-industry-developing-a-conducive-ecosystem-on-feb-18-112842022-02-17T00:00:00+05:30always0.9https://www.indianpharmapost.com/nirsevimab-ema-regulatory-submission-accepted-under-accelerated-assessment-112962022-02-17T00:00:00+05:30always0.9